Rottinghaus Scott T.
- SEC CIK
- 0001942407
In the past year, 1 open-market sale filing worth $11.4K and no purchases.
Current role at each company
- ENTA Enanta Pharmaceuticals IncChief Medical Officeras of Aug 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $11.4K
- 1 filing
- Net
- −$11.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rottinghaus Scott T. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 (view filing) | Dec 5 | Same day | Rottinghaus Scott T.Chief Medical Officer | SSale | −798 | $14.23 | −$11.4K | −3.5%21.8K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Rottinghaus Scott T.Chief Medical Officer | SSale | −866 | $8.06 | −$6.98K | −4.6%17.9K after | 10b5-1 |
| Jul 15, 2024 (view filing) | Jul 11-15 | 4 days | Rottinghaus Scott T.Chief Medical Officer | SSale | −11.9K | $15.97 | −$190.7K | −35.5%21.7K after | 3 lots10b5-1 |
| Dec 6, 2023 (view filing) | Dec 5 | 1 day | Rottinghaus Scott T.Sr. VP & CMO | SSale | −534 | $9.63 | −$5.14K | −2.0%26.5K after |